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Host plant shifts of herbivorous insects may be a ﬁrst step toward
sympatric speciation and can create new pests of agriculturally
important crops; however, the molecular mechanisms that medi-
ate this process are poorly understood. Certain races of the
polyphagous aphid Myzus persicae have recently adapted to feed
on tobacco (Myzus persicae nicotianae) and show a reduced sen-
sitivity to the plant alkaloid nicotine and cross-resistance to neon-
icotinoids a class of synthetic insecticides widely used for con-
trol. Here we show constitutive overexpression of a cytochrome
P450 (CYP6CY3) allows tobacco-adapted races of M. persicae to
efﬁciently detoxify nicotine and has preadapted them to resist
neonicotinoid insecticides. CYP6CY3, is highly overexpressed in
M. persicae nicotianae clones from three continents compared
withM. persicae s.s. and expression level is signiﬁcantly correlated
with tolerance to nicotine. CYP6CY3 is highly efﬁcient (com-
pared with the primary human nicotine-metabolizing P450) at me-
tabolizing nicotine and neonicotinoids to less toxic metabolites
in vitro and generation of transgenic Drosophila expressing CYP6CY3
demonstrate that it confers resistance to both compounds in vivo.
Overexpression of CYP6CY3 results from the expansion of a dinu-
cleotide microsatellite in the promoter region and a recent gene
ampliﬁcation, with some aphid clones carrying up to 100 copies.
We conclude that the mutations leading to overexpression of
CYP6CY3 were a prerequisite for the host shift of M. persicae to
tobacco and that gene ampliﬁcation and microsatellite polymor-
phism are evolutionary drivers in insect host adaptation.
Toxic secondary metabolites produced by many plant speciespresent barriers to host range expansion by phytophagous
insects, and the evolution of mechanisms to circumvent or de-
toxify these antiherbivore defenses is often a prerequisite for a
successful host shift (1–3). Several studies have elucidated the
molecular basis of insect adaptation to plant allelochemicals (4–
7); however, most of these studies have examined adaptation
that has occurred over a long evolutionary time scale and so have
been unable to make direct comparisons with nonadapted con-
speciﬁc races. As a result, identifying the initial genetic changes
that enable a host shift has proved elusive. The recent host shift
to tobacco (Nicotiana tabacum) by the peach–potato aphid,
Myzus persicae, represents one of the few opportunities to study
this evolutionary process in action (8). M. persicae is a globally
distributed highly polyphagous aphid with a host range of >400
species, including many economically important crop plants (9).
Tobacco-adapted races, Myzus persicae nicotianae, are morpho-
logically and genetically differentiated from M. persicae sensu
stricto (s.s.), although there are clear examples of recent gene
ﬂow between the two taxa (10). M. persicae nicotianae have
evolved enhanced tolerance to the pyridine alkaloid nicotine
(11), a potent natural insecticide produced by tobacco and other
members of the Solanaceae family (12); however, the underlying
mechanisms are unknown. Interestingly, tobacco-adapted forms
also show reduced sensitivity to neonicotinoids, an important
class of synthetic insecticides widely used for control that are
chemically related to nicotine (11, 13).
One of the most important superfamilies of enzymes used by
insect herbivores to detoxify xenobiotics, including the secondary
metabolites of plants, is the cytochrome P450s (P450s) (14).
Among the most well characterized examples of P450-mediated
detoxiﬁcation of plant allelochemicals is that of furanocoumarin
metabolism within the genus Papilio (swallowtail butterﬂies) (15).
Members of the P450 CYP6B gene subfamily are induced in
several Papilio species by dietary furanocoumarin as a result of
xanothotoxin-responsive elements in their promoters (4, 16, 17).
The inducibility of individual P450s isolated from different spe-
cies and their activity (substrate speciﬁcity for, and turn-over of,
different furanocoumarins) display a strong correlation with the
ecology of the different species (i.e., frequency of exposure to
furanocoumarins) (18, 19). In the case of other insect species
that have adapted to nicotine-producing plants, P450s have also
been implicated in detoxiﬁcation in the case of the tobacco
hornworm, Manduca sexta (20). This tobacco specialist employs
a putative alkaloid pump at the blood–brain barrier coupled with
detoxifying enzymes to provide a metabolic blood–brain barrier
to nicotine. Although there is evidence that the detoxiﬁcation
enzymes involved in this process are P450s, the speciﬁc enzyme(s)
involved has never been identiﬁed.
In the present study, we used a range of molecular, biochem-
ical, and transgenic approaches to (i) identify the metabolic
process which M. persicae nicotianae has evolved to detoxify
nicotine and so allow colonization of tobacco, (ii) determine
the genetic changes (mutations) underpinning this adaptation,
and (iii) determine whether the development of the mecha-
nism to detoxify nicotine has preadapted these races to resist
neonicotinoid insecticides.
Signiﬁcance
Insect host shifts may lead to sympatric speciation and can
create new crop pests, however identifying the genetic changes
involved has proved elusive. We studied a subspecies of the
aphid Myzus persicae that has recently host shifted to tobacco
and are resistant to the plant alkaloid nicotine. We found these
races overexpress a cytochrome P450 enzyme (CYP6CY3) that
allows them to detoxify nicotine and also certain synthetic
insecticides. Overexpression of CYP6CY3 is caused by gene am-
pliﬁcation (up to 100 copies) and expansion of a dinucleotide
microsatellite in the promoter. Our ﬁndings provide insights
into the molecular drivers of insect host shifts.
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Results and Discussion
M. persicae nicotianae Is Resistant to Nicotine. Five tobacco-adap-
ted clones of M. persicae nicotianae (5410R, T25, JR, 926B, and
5191A) and three unadapted clones of M. persicae s.s. (4106A,
NS, and 4255A) of diverse geographic origin were used in this
study (Materials and Methods). Several of theM. persicae nicotianae
clones have been shown to be resistant to nicotine and/or neon-
icotinoids previously (11, 21–23). We used an artiﬁcial feeding
bioassay to conﬁrm that all M. persicae nicotianae clones are able
to survive for 144 h on a diet containing 30 ppm nicotine. In
contrast, all M. persicae s.s. clones showed 100% mortality at this
time point on this diet (Fig. 1A). At higher nicotine concen-
trations (200 ppm), variability in the level of nicotine tolerance
of the ﬁve M. persicae nicotianae clones was observed, with JR
the most sensitive (100% mortality at 144 h) and 5410R the most
resistant (7% mortality) (Fig. 1A).
CYP6CY3 Is Overexpressed in M. persicae nicotianae Compared
with M. persicae s.s. A previous study on the molecular basis of
neonicotinoid resistance in M. persicae sensu lato compared
global gene expression levels in the M. persicae nicotianae clone
5191A with the M. persicae s.s. clone 4106A using custom
microarrays (23). A single P450 gene (CYP6CY3) was found to
be highly and constitutively overexpressed (∼22-fold) in the
5191A clone. In the present study, we used quantitative PCR to
show that CYP6CY3 is highly overexpressed (10- to 75-fold) in all
ﬁve M. persicae nicotianae clones compared with the M. persicae
s.s. clones (Fig. 1B). Furthermore, CYP6CY3 expression levels
were signiﬁcantly correlated with observed mortality after feed-
ing on 200 ppm nicotine (R2 = 0.91, P = 0.0003). Interestingly,
CYP6CY3 was overexpressed in two M. persicae nicotianae
clones, JR and 926B, that have been shown previously to be
resistant to neonicotinoid insecticides (21, 22). Signiﬁcantly, both
of these clones were collected and established before the in-
troduction of neonicotinoids in 1991 (21, 22), indicating that
CYP6CY3 overexpression has not evolved as a result of selection
from this insecticide class but rather may have evolved to allow
enhanced detoxiﬁcation of nicotine during adaptation to tobacco.
To investigate this possibility further, we examined the ability of
heterologously expressed CYP6CY3 to metabolize nicotine
and neonicotinoids.
Recombinant CYP6CY3 Metabolizes Nicotine and Neonicotinoids in
Vitro to Less-Toxic Metabolites. CYP6CY3 was coexpressed with
the Drosophila melanogaster cytochrome P450 reductase in Sf9
insect cells with 100 pmol P450/mg protein obtained from iso-
lated membranes. Incubation of microsomal preparations con-
taining P450/cytochrome P450 reductase (CPR) with nicotine
demonstrated that CYP6CY3 is highly effective at metabolizing
nicotine with 90% of a 10 μM solution metabolized in 60 min
(Fig. 2A). We were unable to source reference standards for all
known nicotine metabolites, however, based on molecular mass
(161.1073 Da) and the metabolic fate of nicotine in humans (Fig.
S1) the primary metabolite produced was predicted to be Δ1′(5′) or
Δ1′(2′) iminium ion (theoretical mass of 161.1079 Da) (Fig. 2C). As
shown in Fig. S1, these intermediates would be further processed in
vivo to cotinine and aminoketone, respectively. Neither of these was
found to cause any mortality to either M. persicae subspecies in
bioassays using 2,000-ppm solutions of either compound, clearly
demonstrating that CYP6CY3 detoxiﬁes nicotine. When honeydew
collected from M. persicae nicotianae fed on nicotine was analyzed
by liquid chromatography tandem mass spectrometry (LC-MS/MS),
aminoketone was present at a fourfold higher amount than cotinine
(Fig. 2D), suggesting CYP6CY3 primarily metabolizes nicotine to
Δ1′(2′) iminium ion. As this is one of the P450-mediated pathways of
nicotine metabolism in humans (24), the efﬁciency of nicotine
metabolism by CYP6CY3/insect CPR was compared with CYP2A6/
human CPR the main high-afﬁnity metabolizer of nicotine in
humans (24). Based on substrate depletion, CYP6CY3 metabolizes
nicotine more efﬁciently than CYP2A6 (Fig. 2B). The ability of
both CYP6CY3 and CYP2A6 to metabolize two neonicotinoids,
imidacloprid and clothianidin, was also examined. CYP6CY3
metabolizes imidacloprid to 5-hydroxy-imidacloprid (0.82 ±
0.04 pmol metabolite/min/pmol P450) and clothianidin to the n-
desmethylated form thiazolylnitroguanidine (TZNG; 1.33 ± 0.13
pmol metabolite/min/pmol P450). Both of these metabolites have
been shown to be less toxic to aphids than the parent insecticide
(25). Interestingly, human CYP2A6 also metabolizes both
neonicotinoids but with lower efﬁciency (0.29 ± 0.03 pmol 5-hy-
droxy-imidacloprid/min/pmol P450 and 0.07 ± 0.01 pmol TZNG/
min/pmol P450). These results clearly demonstrate that the active
site of both CYP6CY3 and CYP2A6 can accommodate and
metabolize both plant- and man-made antiherbivory compounds,
albeit with different efﬁciency. The capacity of polyphagous
insects and mites to evolve metabolic resistance to synthetic
insecticides/acaricides has been suggested to result from the re-
cruitment of detoxiﬁcation mechanisms that have evolved to
process plant allelochemicals (26). Our ﬁndings now provide clear
evidence that this is true for the aphid M. persicae nicotianae.
Transgenic Expression of CYP6CY3 in Drosophila melanogaster Con-
fers Resistance to Nicotine and Neonicotinoids in Vivo. To conﬁrm
that CYP6CY3 can confer resistance to nicotine and a neon-
icotinoid in vivo we generated a transgenic D. melanogaster strain
containing an intact copy of the aphid CYP6CY3 gene on chro-
mosome 2. This transgene was conﬁrmed by quantitative PCR to
be constitutively expressed in adult ﬂies with male ﬂies express-
ing higher levels of CYP6CY3 than female ﬂies (Fig. S2). For this
reason, the ability of male ﬂies expressing the transgene to resist
nicotine and a neonicotinoid (clothianidin) was examined in oral
bioassays. These ﬂies displayed signiﬁcant resistance to both com-
pounds (Fig. 3) compared with control progeny (ﬂies of the same
genetic background without the CYP6CY3 transgene), demon-
strating unequivocally that transcription of CYP6CY3 alone is
sufﬁcient to give a resistant phenotype.
CYP6CY3 Is Overexpressed in M. persicae nicotianae as a Result of
Gene Ampliﬁcation and Is Enhanced by a Polymorphic Dinucleotide
Microsatellite. To identify the mutations that underlie CYP6CY3
overexpression in M. persicae nicotianae we used quantitative
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Fig. 1. Response to nicotine and changes in copy number and mRNA ex-
pression of CYP6CY3 inM. persicae nicotianae andM. persicae s.s. clones. (A)
Mean mortality ± SE (n = 3) after feeding on nicotine (30 and 200 ppm) for
144 h. (B) Fold change in CYP6CY3mRNA expression and copy number. Error
bars indicate 95% conﬁdence intervals (n = 3).
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PCR and genome walking to look for gene copy number varia-
tion and cis-acting regulatory mutations in the 5′ putative pro-
moter region. Ampliﬁcation of CYP6CY3 has been associated
previously with resistance to neonicotinoids in the clone 5191A
(23). In the present study, we found CYP6CY3 overexpression in
all M. persicae nicotianae clones, is due, at least in part, to gene
ampliﬁcation, with tobacco-adapted clones showing a 7- to 49-
fold increase in gene copy number (from 2 copies in the diploid
M. persicae s.s. clones to 14–100 copies in the M. persicae nic-
otianae clones) (Fig. 1B). Sequencing of CYP6CY3 coding se-
quence revealed very little sequence variation either between or
within any of the M. persicae s.l. clones, suggesting the ampliﬁ-
cation has occurred recently. In terms of interaphid clonal vari-
ation two SNPs are present in the eight aphid clones, a synonymous
SNP at nucleotide position 642 and a nonsynonymous SNP at
position 74 causing a threonine to isoleucine substitution in the
region encoding the transmembrane anchor of the P450 protein
which would not be predicted to affect catalytic activity (Fig. S3).
In terms of intraaphid clonal variation, two alleles are present
in all three M. persicae s.s. clones distinguished by a single G/A
SNP resulting in either a glutamic acid or lysine amino acid at
this position (Fig. S3). For all M. persicae nicotianae clones, only
a single CYP6CY3 coding sequence allele was detected (Fig. S3).
The identical CYP6CY3 nucleotide sequence in ﬁve M. persicae
nicotianae clones from three continents supports a single origin
and global spread of the ampliﬁcation event.
Beyond insects, the best documented examples of P450 gene
ampliﬁcation come from human P450s, speciﬁcally CYP2A6 and
CYP2D6. Remarkably, both of these are involved in nicotine
metabolism. CYP2A6 is duplicated in certain humans who show
increased levels of nicotine metabolites in blood plasma and
modiﬁed smoking behavior (27). CYP2D6 plays a more minor
role in nicotine metabolism, but humans with up to 13 active
copies, known as “ultrarapid metabolizers,” can metabolize nic-
otine and a range of other xenobiotics (including many thera-
peutic drugs) more rapidly than humans of normal copy number
(28). The evolutionary parallels between human CYP2D6 and
aphid CYP6CY3 continue further as ampliﬁcation of both may
have evolved as a mechanism to overcome plant secondary
metabolites that defend against human and/or insect herbivory.
CYP2D6 has a very high afﬁnity for plant alkaloids and ampliﬁ-
cation of this P450 has been suggested to have arisen in North
East Africa (where a high frequency of the population have the
gene ampliﬁcation) to allow previously toxic plants to be exploited
during periods of famine (28).
For all but one of the M. persicae nicotianae clones (JR), the
increase in CYP6CY3 gene copy number is approximately half
the increase in the level of mRNA expression (Fig. 1B), sug-
gesting that additional factor(s) underlie the change in expres-
sion level in four of the ﬁve clones. To identify additional regu-
latory mutations, a ∼1.5-kb region of the putative 5′ promoter
region of CYP6CY3 in all M. persicae s.s. and M. persicae nic-
otianae clones was PCR ampliﬁed by genome walking, cloned,
and sequenced. Only two main sequence differences were ob-
served between the M. persicae s.s. clones and the majority of the
M. persicae nicotianae clones: a single A/G SNP 138 bp upstream
of the translational start codon and a signiﬁcant change in length
of a AC(n) dinucleotide repeat (198 bp upstream of the start
codon) from 15 repeat units inM. persicae s.s. clones to 48 repeat
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Fig. 2. Metabolism of nicotine by recombinantly
expressed aphid (CYP6CY3) and human (CYP2A6)
P450s. (A) The recovery of nicotine after 10 μM nic-
otine was incubated with 50 pmol P450+reductase in
the presence or absence of NADPH for 60 min. Mean
data ± SD (n = 6). (B) Rate of nicotine metabolism
with increasing nicotine concentration. The appar-
ent kcat and Km values were calculated as kcat of
56.41 ± SEM (n = 3) 6.18 pmol metabolite/min/pmol
P450 and Km of 30.00 ± 8.06 μM for CYP6CY3, and
kcat of 21.03 ± 4.11 and Km of 31.25 ± 10.77 μM for
CYP2A6. (C) High-resolution mass spectrum of the
major metabolite [the peak at m/z 161.1079 corre-
sponds to the theoretical mass of nicotine-Δ1′(5/2′)-imi-
nium ion]. (D) Amount of cotinine and aminoketone
in aphid honeydew after feeding on nicotine-treated
leaf discs for 48 h.
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Fig. 3. Bioassays with transgenic Drosophila expressing CYP6CY3. (A and B)
Mortality of transgenic CYP6CY3 male ﬂies (Exp) to nicotine (A) and clo-
thianidin (B) compared with controls (Control), which do not have the P450
transgene. Error bars indicate SE (n = 6–9). Asterisks indicate a signiﬁcant
difference in mortality between experimental and control lines. *P < 0.05,
**P < 0.01.
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units in M. persicae nicotianae clones (Fig. 4A and Fig. S4). In-
terestingly, the exception to this was the M. persicae nicotianae
clone JR, which like the M. persicae s.s. clones lacks the micro-
satellite expansion. This is the only M. persicae nicotianae clone
where the fold-change increase in CYP6CY3 gene copy number is
equal to the increase seen in the level of mRNA expression (Fig.
1B), suggesting that the microsatellite polymorphism or the A/G
SNP may play a functional role in further enhancing CYP6CY3
expression. To explore this possibility, the ∼1.5-kb region upstream
of CYP6CY3 was PCR-ampliﬁed from the 5191A and 4106A
clones and cloned into the reporter gene vector pGL3. Reporter
gene assays showed that the M. persicae nicotianae promoter
insert drove around twofold greater reporter gene expression
than the M. persicae s.s. insert (Fig. 4B). To examine whether the
increase in AC(n) length or the single A/G SNP was responsible,
site-directed mutagenesis was used to change the adenine at
position −138 bp present in the M. persicae nicotianae promoter
to a guanine, mimicking the situation inM. persicae s.s. When the
activity of this mutated insert was compared with the M. persicae
nicotianae promoter insert, no reduction in reporter gene ex-
pression was observed (Fig. 4B), indicating that it is the increase
in length of the AC(n) repeat that is exclusively responsible for
the expression difference. To investigate this possibility further,
a series of synthetic versions of theM. persicae s.s. promoter were
synthesized with AC(n) repeat lengths of AC(15), AC(30), AC(45),
and AC(60). When these inserts were used in reporter gene
assays, enhanced expression was only observed for the AC(45)
and AC(60) constructs (Fig. 4C). Furthermore, no signiﬁcant
differences in expression were observed between the two longest
or the two shortest constructs, suggesting a threshold effect. This
ﬁnding also suggests that the AC(48) repeat seen in most of the
M. persicae nicotianae clones is the optimal length for enhancing
the expression of CYP6CY3. We note that these ﬁndings are
somewhat in contrast to previous studies where increases in the
length of dinucleotide repeats show a more linear relationship
with gene expression (29).
Microsatellites including AC(n) repeats have been historically
considered nonfunctional neutral markers or “junk DNA.”
However, there is now mounting evidence that they may be
important cis-regulatory DNA sequences that have direct in-
ﬂuence on both gene expression and phenotypic variation (30).
Studies on humans where polymorphic AC(n) microsatellites are
overrepresented in the genome have suggested they may in-
ﬂuence transcription by binding transcription factors or by af-
fecting DNA conformation (30). In yeast, polymorphic tandem
repeats in promoters may facilitate gene expression by affecting
local chromatin structure consistent with a role as “evolutionary
tuning knobs” that mediate rapid evolution of gene expression
(29). Our ﬁndings demonstrate that dinucleotide microsatellite
variation is also a driver of adaptive change in gene expression
during insect evolution.
Analysis of intraaphid clone sequence variation within the
∼1.5-kb region of the putative 5′ promoter region revealed two
variant promoter sequences in all M. persicae s.s. clones (distin-
guished by a G/A SNP at position −545, Fig. S4), both of which
lack the microsatellite expansion. Two alleles were also detected
in clone JR (distinguished by a G/A SNP at position −138 bp,
Fig. S4), both of which lack the microsatellite expansion. For all
other M. persicae nicotianae clones, only a single promoter allele
with the tandem repeat expansion was observed (Fig. S4). The
ﬁnding that, for four of the M. persicae nicotianae clones, all
ampliﬁed copies of CYP6CY3 appear to share the microsatellite
expansion suggests that this mutation predates the gene ampliﬁ-
cation event. Similar time courses of cis-acting mutation followed
by duplication have been described for P450s associated with
insecticide resistance in fruit ﬂies and mosquitoes (31, 32).
Summary
The genetic structure of global M. persicae s.l. populations sug-
gests that adaptation to tobacco arose as a recent, single evolu-
tionary event, originating in East Asia, where tobacco-adapted
forms were ﬁrst reported (33); our ﬁndings are consistent with
this. We conclude that the mutations leading to overexpression
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Fig. 4. CYP6CY3 promoter analysis inM. persicae nicotianae
and M. persicae s.s. (A) Alignment of a region of the 5′
putative promoter region immediately upstream of the
translation start codon of CYP6CY3 highlighting two poly-
morphisms, an A/G SNP at position −138 bp and a change in
length of an AC(n) dinucleotide repeat at position −198 bp.
(B) Reporter gene activity (normalized to renilla ﬂuores-
cence) of the 5′ putative promoter regions of CYP6CY3
ampliﬁed from the M. persicae clone 4106A and the
M. persicae nicotinae clone 5191A. The activity of a mutated
version of the 5191A promoter (5191Asdm), which has an
A/G SNP present in the 5191A promoter corrected is also
shown along with pGL3 and shuttle constructs (both con-
trols). (C) Reporter gene activity of synthetic promoter
constructs with different lengths of the AC(n) dinucleotide
repeat. For B and C, mean data ± SD (n = 4) is shown.
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of CYP6CY3 were a prerequisite for the host shift of M. persicae
to tobacco. Furthermore, the recruitment of this detoxiﬁcation
mechanism preadapted this subspecies to resist neonicotinoids,
a globally important class of insecticide. We suggest that muta-
tion of a microsatellite was the initial step in this process and that
subsequent gene ampliﬁcation greatly enhanced expression of
this gene. These results provide fundamental insights into the
evolutionary processes that underlie the genotypic and pheno-
typic changes that are involved in insect host shifts and we en-
visage that both gene ampliﬁcation and dinucleotide microsatellites
may be an important source of genetic variation for adaptive
evolution in other insect species.
Materials and Methods
Aphid Clones. Clones 4106A, NS, and 4255A are clones of M. persicae s.s.
collected from potatoes in Scotland in 2000, from an unrecorded plant in
Germany (Bonn) in 1967, and from oilseed rape in the United Kingdom in
circa 2000, respectively. Clones 926B, 5191A, and T25 are clones ofM. persicae
nicotianae collected in Greece from tobacco in 1990, 2007, and 2007; 5410R
is a clone of M. persicae nicotianae collected from tobacco in Zimbabwe in
2010. Clone JR was collected from eggplants (a member of the Solanacae
that contains relatively high levels of nicotine; ref. 34) in Toyoda, Japan, in
1983 but was found to readily accept tobacco (22). Japanese populations
of M. persicae nicotianae are difﬁcult to distinguish from M. persicae s.s.,
but morphological examination suggested JR is “a tobacco feeding form of
M. persicae closely related to the tobacco aphidM. persicae nicotianae” (22).
We refer to it in this study asM. persicae nicotianae. JR was previously found
to be 10-fold resistant to nicotine compared with theM. persicae strain NS in
an oral feeding assay and 7-fold resistant to the neonicotinoid imidacloprid
in a leaf-dip bioassay (22). Clone 926B showed ﬁvefold resistance to nicotine
in fumigation bioassays and 11-fold resistance to imidacloprid rising to 100-
fold resistance to the neonicotinoid clothianidin compared with the M.
persicae clone 4106A (11, 21). Clone 5191A was recently shown to be 30- to
40-fold resistant to several neonicotinoids compared with 4106A (23).
Aphid Bioassays.Nicotine (Sigma) was dissolved directly into an aphid artiﬁcial
diet (35) and ﬁlter sterilized. A total of 0.5 mL was pipetted onto the end of
a plastic cylinder (size: 25 mm deep, 25 mm internal diameter) that had been
sealed with stretched Paraﬁlm. A second layer of Paraﬁlm was then
stretched on top of this to form a sachet. Ten adult apterous aphids were
transferred into the cylinder and the remaining opening sealed with Par-
aﬁlm. Three replicates were used for each concentration and mortality was
assessed after 144 h at 18 °C under a 16:8 h light:dark regime. Mortality was
controlled for by feeding aphids on artiﬁcial diet without nicotine under the
same conditions.
Quantitative RT-PCR. Quantitative PCR was used to examine the expression of
CYP6CY3 and changes in gene copy number using the primers CYP6F and
CYP6R (Table S1) as described (23). Data were analyzed according to the
ΔΔCT method (36), using the geometric mean of two housekeeping genes
(actin and para, which encodes the voltage-gated sodium channel) for
normalization according to the strategy described previously (37).
CYP6CY3 Coding Sequence Analysis. The coding sequence of CYP6CY3 was
ampliﬁed from cDNA (prepared as described above) using primers CY3CDSF
and CY3full R2 (Table S1). PCR reactions (20 μL) consisted of 1 unit of Kappa
high-ﬁdelity polymerase (Kappa Biosystems), 4 μL of PCR buffer containing
10 mM magnesium chloride, 1 μL of 10 mM dNTPs, 1 μL of each primer (10
mM), and 2 μL of cDNA. Temperature cycling conditions were 95 °C for 1 min
followed by 35 cycles of 95 °C for 30 s, 55 °C for 30 s and 72 °C for 2 min,
followed by a ﬁnal extension of 72 °C for 10 min. Ampliﬁed fragments were
visualized on 1% agarose gels, puriﬁed using the Wizard SV Gel kit and PCR
Clean-Up System (Promega), and either “direct sequenced” or cloned (using
the Strataclone PCR Cloning kit; Agilent Technologies) and sequenced using
primers CY3seqF and CY3seqR (Table S1).
Genome Walking and Promoter Analysis of CYP6CY3. The GenomeWalker
Universal Kit (Clontech) was used to PCR amplify the genomic DNA sequence
upstream of CYP6CY3. DNA was extracted from a pool of ﬁve adult aphids
of the 5191A clone using the DNeasy Plant DNA Mini Kit (Qiagen) and used
for genome walking following the manufacturer’s protocol with the primers
shown in table S1. PCR products were recovered from agarose gels, cloned
using the Strataclone PCR Cloning kit (Agilent Technologies) and sequenced.
Speciﬁc primers were then designed (Table S1) and used to characterize the
∼1.5-kb putative promoter region immediately upstream of the translation
start codon of CYP6CY3 of all of the aphid clones used in this study. PCR
products were sequenced directly or cloned and sequenced as described for
the characterization of CYP6CY3 coding sequence. For reporter gene assays,
the same 1.5 kb of promoter sequence was ampliﬁed from DNA extracted
from aphid clones 5191A and 4106A in PCR using a high ﬁdelity taq (Ad-
vantage 2 polymerase, Clontech), the conditions detailed above and primers
CY3hindIIIR and CY3sac1F (Table S1). Following excision with HindIII and SacI
these were ligated into pGL3-Basic (Promega) and transformed into XL1-
Blue (Agilent). Plasmids were extracted with the GeneJet plasmid miniprep
kit (Fermentas), sequenced and then adjusted to 300 ng/μL for use in dual
luciferase assays using the An. gambiae cell line Sua5.1 maintained in
Schneider’s Drosophila medium supplemented with 10% FCS and 1% peni-
cillin/streptomycin. Approximately 5 × 105 cells per well were plated into 24-
well plates 1 d before transfection and allowed to reach 60–70% conﬂuency.
Qiagen effectene transfection reagent was used for transfection of con-
structs, and the Dual-Luciferase Reporter Assay (Promega) used for promoter
activity measurements. Reporter constructs (600 ng, CYP6CY3 upstream
sequences in pGL3-Basic) and pGL3 without insert or 600 ng of shuttle
construct pSLfa1180fa as controls (http://ﬂybase.org/reports/FBmc0002761.
html) were cotransfected with 1 ng of actin-Renilla internal control in 60 μL
of DNA condensation buffer, 4.8 μL of enhancer and 6 μL of effectene in
triplicate. Following incubation at 27 °C for 48 h and washing of cells
with PBS, cells were harvested in 100 μL passive lysis buffer (Promega) and
luciferase activity measured on a luminometer (EG&G Berthold). Construct
luciferase activity was normalized to Renilla luciferase activity. The Quik-
Change II Site-Directed Mutagenesis kit (Agilent) was used with primers
CY3SDMF and CY3SDMR (Table S1) to change an adenine nucleotide at
position −198 bp in the M. persicae nicotianae promoter to a guanine. The
plasmids obtained were sequenced to identify promoter constructs con-
taining the nucleotide change. Finally, a series of synthetic versions of ∼1.5
kb of the M. persicae 4106A promoter were synthesized (GeneArt, Life
Technologies) where the AC(n) repeat length present ∼200 bp upstream of
the translational start codon was changed in length to, AC(15), AC(30), AC(45),
and AC(60). These were then cloned into pGL3-Basic and used in reporter
assays as described above.
Heterologous Expression of CYP6CY3. CYP6CY3 (GenBank accession no.
HM009309) and the D. melanogaster (DROME) NADPH-dependent CPR
(GenBank accession no. Q27597) were obtained by gene synthesis (Geneart)
and inserted into the pDEST8 expression vector (Invitrogen). The PFastbac1
vector with no inserted DNA was used to produce a control virus. The
recombinant baculovirus DNA was constructed and transfected into Sf9
insect cells (Gibco) using the Bac-to-Bac baculovirus expression system
(Invitrogen) according to the manufacturer’s instructions. The titer of the
recombinant virus was determined following standard protocols of the
supplier. Sf9 cells were maintained in suspension culture under serum-free
conditions (SF-900 II SFM, Gibco) at 27 °C containing 25 μg/mL−1 gentamycin
(Gibco). Insect cells grown to a density of 2 × 106 cells per mL−1 were
coinfected with recombinant baculoviruses containing CYP6CY3 and CPR
with various multiplicity of infection (MOI) ratios to identify the best con-
ditions. Control cells were coinfected with the baculovirus containing vec-
tor with no insert (ctrl-virus) and the recombinant baculovirus expressing
CPR using the same MOI ratios. Ferric citrate and δ-aminolevulinic acid
hydrochloride were added to a ﬁnal concentration of 0.1 mM at the time of
infection and 24 h after infection. After 60 h, cells were harvested and
washed with PBS, and microsomes of the membrane fraction were pre-
pared according to standard procedures and stored at −80 °C (38). P450
expression and functionality was estimated by measuring CO-difference
spectra in reduced samples (38). The protein content of samples was de-
termined using Bradford reagent (Sigma) and BSA as a reference.
Metabolism Assays and Ultra-Performance LC-MS/MS Analysis. Metabolism of
nicotine and neonicotinoids (imidacloprid and clothianidin) was assayed
by incubating recombinant CYP6CY3/CPR (2 pmol P450 per assay) or ctrl-
virus/CPR microsomes in 0.1 M potassium phosphate buffer with an NADPH-
regenerating system (Promega; 1.3 mM NADP+, 3.3 mM glucose-6-phos-
phate, 3.3 mM MgCl2, 0.4 U/mL
−1 glucose-6-phosphate dehydrogenase) and
substrate (12.5 μM; 0.8–100 μM for enzyme kinetics) at 27 °C for 1 h. The
total assay volume was 200 μL using three replicates for each data point.
Microsomes incubated without NADPH served as a control. The assay was
quenched by the addition of ice-cold acetonitrile (to 80% ﬁnal concentra-
tion) and centrifuged for 10 min at 3,000 × g, and the supernatant sub-
sequently analyzed by tandem mass spectrometry as described (39). For the
chromatography, acetonitrile/water/0.1% formic acid was used as eluent in
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gradient mode. For detection and quantiﬁcation, the multiple reaction
monitoring transitions 163 > 117 (nicotine); 177 > 80 (cotinine); 179 > 106
(aminoketone); 256 > 175 (imidacloprid); 250 > 132 (clothianidin) were
monitored. Recovery rates of parent compounds using microsomal fractions
without NADPH were normally close to 100%. Substrate turnover from two
independent reactions were plotted vs. controls. Michaelis–Menten kinetics
were determined using GraphPad Prism version 5 (GraphPad Software).
Analysis of Aphid Honeydew. Leaf discs were dipped in aqueous nicotine
(2,000 ppm) containing 0.1% (wt/vol) Triton X-100, allowed to dry for 30 min,
and then placed on a bed of agar in a small vented Petri dish. Ten aphids of
clone JR were placed on the leaf disk, the lid of the Petri dish was sealed, and
the dish was stored inverted for 48 h. Five replicates were prepared in this
way. Aphid honeydew that had collected on the lid of the Petri dish was
washed off in 500 μL of water and analyzed for the presence of aminoketone
and cotinine by ultra-performance LC-MS/MS analysis as detailed above.
Transgenic Expression of CYP6CY3 in D. melanogaster. CYP6CY3 was PCR
ampliﬁed using primers CY3Xba1F and CY3HindIIIR (Table S1) following the
conditions described above. Following digestion with HindIII and XbaI, the
PCR amplicon was ligated into a modiﬁed pattB vector that had been
digested with the same enzymes and transformed into XL1-Blue (Agilent).
Using the PhiC31 system, clones were transformed into the germ line of a D.
melanogaster strain carrying the attP docking site on chromosome 2
[“y1w67c23; P attP”, “1;2”] (40). The transgenic line was obtained and
balanced, and the integration of the intact gene was conﬁrmed by PCR and
sequencing as described above. Bioassays were used to assess the suscepti-
bility of adult male ﬂies to nicotine and the neonicotinoid insecticide clo-
thianidin. Compounds were dissolved in molten 0.5% agarose containing
5% (wt/vol) sugar, and 2 mL was allowed to set in the bottom of 15-mL
falcon tubes. Adult ﬂies (15–20, 2–5 d post eclosion) were then added to the
tubes, and the mortality by oral ingestion was assessed at several time points
spanning 1–74 h. Mortality was compared with control progeny (ﬂies of the
same genetic background but without CYP6CY3). Six to nine replicates were
carried out for each concentration. Mortality due to factors other than in-
secticide was controlled using tubes containing agarose/sucrose minus in-
secticide. Unpaired Student t tests were used to compare the mortality of
each experimental group with each control group for each time point. To
conﬁrm the expression of CYP6CY3 in the experimental group and the ab-
sence of expression in the control group, total RNA was extracted from three
pools of ﬁve ﬂies of each, and cDNA was synthesized as described above.
Quantitative PCR was performed using the synthesized cDNA as template as
described above but using the Drosophila RPL11 housekeeping gene for
normalization (Table S1).
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Fig. S1. Cytochrome P450-mediated pathways of nicotine metabolism in humans. Adapted from ref. 1.
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Fig. S2. Relative expression of CYP6CY3 in transgenic Drosophila melanogaster. Expression levels of CYP6CY3 relative to the housekeeping gene RP11 are
shown for females (A) and males (B) of the transgenic strain and the control samples with no transgene expression. Error bars show SE.
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Fig. S3. Alignment of the full coding sequence of CYP6CY3 in Myzus persicae nicotianae and Myzus persicae clones. Single-nucleotide polymorphisms are
highlighted.
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Fig. S4. Alignment of the 1.5 kb immediately upstream of CYP6CY3 in M. persicae nicotianae and M. persicae clones. Single-nucleotide polymorphisms are
highlighted.
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Table S1. Sequences of oligonucleotide primers used in this study
Primer name Sequence Purpose
CYP6F CGG GGT GAC GAT CAT CTA TT QPCR of CYP6CY3
CYP6R GGG TGG TCT TTT GAC AAA GC QPCR of CYP6CY3
MpActF1 GGT GTC TCA CAC ACA GTG CC QPCR ampliﬁcation of the actin reference gene
MpActR1 CGG CGG TGG TGG TGA AGC TG QPCR ampliﬁcation of the actin reference gene
Aph1R TGG TAT ACA CGT TGG TTC TC QPCR ampliﬁcation of the para reference gene
Aph18 GAC CAC GAG CTT CCC CGG TG QPCR ampliﬁcation of the para reference gene
CY3 hindIIIr AAT TAA GCT TCC TGG TCG GTA TTA TAA AC Cloning of CYP6CY3 into PGL3
CY3 sac1Fbig AAT TGA GCT CAC TAT TAG GTA AGA CAT ACA Cloning of CYP6CY3 into PGL3
CY3SDMF GAA GTG ATT CAG ATA ACC CCA CCG AAT TAG ACG GTG CTG GTA C Site-directed mutagenesis of CYP6CY3 in PGL3
CY3SDMR GTA CCA GCA CCG TCT AAT TCG GTG GGG TTA TCT GAA TCA C Site-directed mutagenesis of CYP6CY3 in PGL3
CY3CDSF ATT GTT TAT AAT ACC GAC CAG GC PCR ampliﬁcation of CYP6CY3 coding sequence
CY3fullR2 ACA ATT TTC TCA GGT TAC GAA CTG PCR ampliﬁcation of CYP6CY3 coding sequence
Cy3seqR GTC AAT TCA TTT CTT GCC TGC Sequencing the coding sequence of CYP6CY3
Cy3SeqF AGC TGT GCC TGA TGG TGA C Sequencing the coding sequence of CYP6CY3
Cy3Xba1F AAT TTC TAG AAT GAA TCT ATC ATC GTC AAC Cloning of CYP6CY3 into pUASattB
Cy3HindIIIR AAT TAA GCT TAA TTC TTA ACT AAA GTT AAG C Cloning of CYP6CY3 into pUASattB
Gw 5′ r1 CAG TCG GTG GTT GAC GAT GAT AGA TTC A Genome walking
Gw 5′ r2 CTA AAC ACG CCG AGG CGA TAT AAA TCC A Genome walking
Pro CY3 r1 CAG TCG GTG GTT GAC GAT GAT AGA TTC A PCR ampliﬁcation of CYP6CY3 promoter region
Cy3F pro outer 1 AGA ACT ACG TTG GGC CAC GT PCR ampliﬁcation of CYP6CY3 promoter region
Cy3F medium outer CTG ACT ATT AGG TAA GAC ATA CAG Sequencing the CYP6CY3 promoter region
Gw 5′ r1 CAG TCG GTG GTT GAC GAT GAT AGA TTC A Sequencing the CYP6CY3 promoter region
Cy3med seqf ATA ACA GCG CAC TGT TTG TT Sequencing the CYP6CY3 promoter region
Cy3seqR CAT GTT ACC GAA TGT ACC TA Sequencing the CYP6CY3 promoter region
RPL11-F CGA TCC CTC CAT CGG TAT CT QPCR of transgenic Drosophila
RPL11-R AAC CAC TTC ATG GCA TCC TC QPCR of transgenic Drosophila
qRSP7sybF GTG TTC GGT TCC AAG GTG AT QPCR of transgenic Drosophila
qRSP7sybR TCC GAG TTC ATT TCC AGC TC QPCR of transgenic Drosophila
All sequences are shown 5′ to 3′. QPCR, quantitative PCR.
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